Language is one of several barriers to inclusivity in clinical trials. In this Vistatec webinar, Citeline’s Lya Rebelo joins panelists in discussing ways to address this challenge.

I feel that even if formal mandates shift, the scientific, ethical, and commercial imperative for inclusive trials remains strong.
Lya Rebelo, Commercial Enablement Manager, Citeline

Related resources

A female scientist in a lab coat holds a tube, conducting experiments in a laboratory setting.
MAY 07, 2024
Article
Clinical

Diversity at the Start: Best Practices for Clinical Trial Planning

Study sponsors should begin their clinical trial diversity efforts with a fit-for-purpose clinical protocol.

White paper cover for Practical Strategies for Ensuring a Diverse Patient Population in Clinical Trials
OCT 25, 2024
White paper
Clinical

Practical Strategies for Ensuring a Diverse Patient Population in Clinical Trials

Clinical trials are becoming more complex. The number of endpoints, procedures, and sites used per study have all increased. This makes recruiting patients — and particularly diverse patients — more difficult. Citeline experts share tips on overcoming these recruitment challenges.

global diversity-resource-card-thumbnail
NOV 06, 2023
Article
Clinical

Clinical Trial Diversity on a Global Scale

Reporting clinical trial racial and ethnic data is a crucial step toward clinical trial diversity. But these definitions can be different across countries.

Darkened Qualified calendar. Please allow all cookies to use functionality.

To enable the booking feature, please enable all cookies in your browser.